全文获取类型
收费全文 | 128634篇 |
免费 | 8676篇 |
国内免费 | 4402篇 |
专业分类
耳鼻咽喉 | 462篇 |
儿科学 | 2746篇 |
妇产科学 | 1786篇 |
基础医学 | 18036篇 |
口腔科学 | 2089篇 |
临床医学 | 9174篇 |
内科学 | 31404篇 |
皮肤病学 | 1709篇 |
神经病学 | 6588篇 |
特种医学 | 2260篇 |
外国民族医学 | 13篇 |
外科学 | 11119篇 |
综合类 | 15482篇 |
现状与发展 | 21篇 |
一般理论 | 1篇 |
预防医学 | 10219篇 |
眼科学 | 1026篇 |
药学 | 15208篇 |
46篇 | |
中国医学 | 5884篇 |
肿瘤学 | 6439篇 |
出版年
2023年 | 1603篇 |
2022年 | 2615篇 |
2021年 | 4388篇 |
2020年 | 3777篇 |
2019年 | 5911篇 |
2018年 | 5110篇 |
2017年 | 4323篇 |
2016年 | 3823篇 |
2015年 | 4072篇 |
2014年 | 7038篇 |
2013年 | 7300篇 |
2012年 | 6957篇 |
2011年 | 7653篇 |
2010年 | 6081篇 |
2009年 | 5787篇 |
2008年 | 5837篇 |
2007年 | 5634篇 |
2006年 | 5030篇 |
2005年 | 4270篇 |
2004年 | 3504篇 |
2003年 | 3076篇 |
2002年 | 2463篇 |
2001年 | 2116篇 |
2000年 | 1728篇 |
1999年 | 1495篇 |
1998年 | 1356篇 |
1997年 | 1148篇 |
1996年 | 994篇 |
1995年 | 971篇 |
1994年 | 869篇 |
1993年 | 693篇 |
1992年 | 639篇 |
1991年 | 539篇 |
1990年 | 459篇 |
1989年 | 412篇 |
1988年 | 353篇 |
1987年 | 313篇 |
1985年 | 1886篇 |
1984年 | 2893篇 |
1983年 | 2569篇 |
1982年 | 2050篇 |
1981年 | 2064篇 |
1980年 | 1745篇 |
1979年 | 1541篇 |
1978年 | 1299篇 |
1977年 | 781篇 |
1976年 | 1223篇 |
1975年 | 1076篇 |
1974年 | 897篇 |
1973年 | 830篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
71.
《Journal of vascular and interventional radiology : JVIR》2020,31(5):760-768.e1
PurposeTo investigate dynamic variables obtained from retrospective computed tomography angiography for ability to predict thoracic endovascular aortic repair (TEVAR) outcomes in patients with complicated type B aortic dissection (cTBAD).Materials and MethodsSeventy-nine patients with cTBAD who received TEVAR from March 2009 to June 2018 were retrospectively enrolled. Relative true lumen area (r-TLA) was computed at the level of tracheal bifurcation every 5% of all R-R intervals. Parameters that reflect the state of intimal motion were evaluated, including difference between maximum and minimum r-TLA (D-TLA) and true lumen collapse. The endpoints comprised early (≤ 30 days) and late (> 30 days) outcomes after intervention.ResultsOverall early mortality rate was 13.9% (11/79), and early adverse events rate was 24.1% (19/79). Patients who received TEVAR within 2 days of symptom onset demonstrated the worst outcomes. A longer time of r-TLA < 25% in 1 cardiac cycle (P = .049) and larger D-TLA (P < .001) were correlated to an increased early death. In addition, D-TLA was an independent predictor of early mortality. Area under the curve of D-TLA was 0.849 (95% confidence interval 0.730–0.967) for predicting early mortality and 0.742 (95% CI 0.611–0.873) for predicting early adverse events. Survival and event-free survival rates during follow-up were decreased in the D-TLA > 21.5% group compared with the D-TLA ≤ 21.5% group (all P < .001).ConclusionsLarger D-TLA is correlated with worse postoperative outcomes and might be a crucial parameter for future risk stratification in patients with cTBAD. 相似文献
72.
《Journal of thoracic oncology》2020,15(1):138-143
IntroductionEGFR mutated (EGFRm) NSCLC tumors occasionally express programmed cell death ligand 1 (PD-L1), although frequency and clinical relevance are not fully characterized. We report PD-L1 expression in patients with EGFRm advanced NSCLC and association with clinical outcomes following treatment with osimertinib or comparator EGFR tyrosine kinase inhibitors in the FLAURA trial (phase III, NCT02296125).MethodsOf 231 tissue blocks available from the screened population (including EGFRm-positive and -negative samples), 197 had sufficient tissue for PD-L1 testing using the SP263 (Ventana, Tucson, Arizona) immunohistochemical assay. Tumor cell (TC) staining thresholds of PD-L1 TC greater than or equal to 1%, TC greater than or equal to 25%, and TC greater than or equal to 50% were applied. Progression-free survival (PFS) was investigator-assessed, per Response Evaluation Criteria in Solid Tumor, version 1.1, according to PD-L1 expressors (TC ≥ 1%) or negatives (TC < 1%) in randomized patients.ResultsPD-L1 staining was successful in 193 of 197 patient formalin-fixed paraffin-embedded blocks; of these, 128 of 193 were EGFRm-positive and 106 of 128 patients were randomized to treatment (osimertinib: 54; comparator: 52). At the PD-L1 TC greater than or equal to 25% threshold, 8% (10 of 128) of EGFRm-positive tumors expressed PD-L1 versus 35% (23 of 65) of EGFRm-negative tumors. With the TC greater than or equal to 1% threshold, 51% (65 of 128) versus 68% (44 of 65) were mutation-positive and –negative, respectively, and with the TC greater than or equal to 50% threshold, 5% (7 of 128) versus 28% (18 of 65), were mutation-positive and -negative, respectively. For PD-L1 expressors (TC ≥ 1%), median PFS was 18.4 months with osimertinib and 6.9 months with comparator (hazard ratio = 0.30; 95% confidence interval: 0.15–0.60). For PD-L1–negative patients (TC < 1%), median PFS was 18.9 months with osimertinib and 10.9 months with comparator (hazard ratio = 0.37; 95% confidence interval: 0.17–0.74).ConclusionsClinical benefit with osimertinib was unaffected by PD-L1 expression status. 相似文献
73.
74.
目的 分析CSTB、A-FABP在膀胱癌诊断和预后的意义。方法 选取2014年1月至2016年7月在本院进行手术、病理证实的膀胱癌患者45例、良性膀胱病变患者88例,检测膀胱癌样本癌组织、癌旁组织、良性膀胱病变组织中CSTB、A-FABP表达水平。评价CSTB、A-FABP在鉴别诊断膀胱癌的效用。对比膀胱癌进展对象(2年内转移、复发、肿瘤死亡)以及未进展对象组织中CSTB、A-FABP表达水平。结果 癌组织、癌旁组织、良性病变对象组织中CSTB、A-FABP表达水平差异有统计学意义(P<0.05)。CSTB、A-FABP作为诊断标准(任意一项为阳性),鉴别诊断膀胱癌与良性病变的灵敏度为84.4%、特异度为90.9%、阳性预测值82.6%、阴性预测值92.0%、符合率88.7%。2年内转移、复发、肿瘤死亡的患者共30例,无转移、复发、死亡的患者共15例,膀胱癌进展对象CSTB、A FABP表达量高于未进展对象,差异有统计学意义(P<0.05)。结论 CSTB、A-FABP在膀胱癌诊断、预后预测中均有一定的临床价值。 相似文献
75.
Sharisse M. Arnold Rehring Liza M. Reifler Jennifer H. Seidel Karen A. Glenn John F. Steiner 《Academic pediatrics》2019,19(5):572-580
ObjectiveClinical specialty societies recommend long-acting reversible contraceptives (LARCs) as first-line contraception for adolescent women. We evaluated whether a combined educational and process improvement intervention enhanced LARC placement in primary care within an integrated health care system.MethodsThe intervention included journal clubs, live continuing education, point-of-care guidelines, and new patient materials. We conducted a retrospective cohort study across 3 time periods: baseline (January 2013?September 2015), early implementation (October 2015–March 2016), and full implementation (April 2016–June 2017). The primary outcome was the proportion of LARCs placed by primary care clinicians among women aged 13 to 18 years compared with gynecology clinicians.ResultsKaiser Foundation Health Plan of Colorado cared for approximately 20,000 women aged 13 to 18 years in each calendar quarter between 2013 and 2017. Overall, LARC placement increased from 7.0 per 1000 members per quarter at baseline to 13.0 per 1000 during the full intervention. Primary care clinicians placed 6.2% of all LARCs in 2013, increasing to 32.1% by 2017 (P < .001), including 45.5% of contraceptive implants. Clinicians who attended educational sessions were more likely to adopt LARCs than those who did not (17.9% vs 6.4% respectively, P = .009). Neither overall LARC placement rates (relative risk, 1.9; 95% confidence interval, 0.7?5.6) nor contraceptive implant rates (relative risk, 3.0; 95% confidence interval, 0.9?9.8) increased significantly in clinicians who attended educational activities.ConclusionsThis multimodal intervention was associated with increased LARC placement for adolescent women in primary care. The combination of education and process improvement is a promising strategy to promote clinician behavior change. 相似文献
76.
《Clinical neurophysiology》2019,130(9):1562-1569
ObjectiveConventional deep brain stimulation (DBS) systems with ring-shaped leads generate spherical electrical fields. In contrast, novel directional leads use segmented electrodes. Aim of this study was to quantify the impedance variations over time in subjects with the directional Cartesia-Boston® system.MethodsImpedance records, programming settings, and clinical data of 11 consecutive Parkinsonian patients implanted with DBS directional leads in two Italian centers (Udine and Vicenza) were retrospectively evaluated. Data were collected before starting stimulation (in the operating room and at days 5 and 40) and after switching stimulation on at the successive follow-up visits (1, 6 and 12 months).ResultsDirectional leads have significantly higher impedance than ring leads. Stimulated contacts had always lower impedance compared to non-stimulated contacts. Before DBS-on, all contacts had higher impedance in the operating room, with an initial decrease five days post-surgery and a subsequent increase at day 40, more evident for directional contacts. The impedance of directional leads increased post-implantation at 1 and 6 months with a plateau at 12 months.ConclusionsThere was a significant difference between the directional and ring leads at baseline (before activation of DBS) and during follow-up (chronic DBS).SignificanceOur study reveals new information about the impedance of segmented electrodes that is useful for patient management during the initial test period, as well as during long-term DBS follow-up. 相似文献
77.
78.
79.